PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). Patented SDC is an electrolytically generated source of stabilized ionic silver. The company’s proprietary high efficacy/low toxicity bioscience technologies represent the global trend toward industry and consumer use of “green” products while providing competitive advantages in efficacy and safety. For more information, visit the company’s Web site at www.purebio.com.

LD Micro is an internet-based newsletter that provides information on selected public companies to self-directed investors. It is anticipated that the two-day LD Micro Conference will be attended by more than 200 institutions focused on micro-cap and small-cap stocks. Last year, a record 580 people attended. For more information, please visit www.ldmicro.com.

Let us hear your thoughts below: